Clinical Trial: PTC-guided Neoadjuvant Therapy For Muscle-invasive Bladder Cancer

U.S., July 9 -- ClinicalTrials.gov registry received information related to the study (NCT07690878) titled 'PTC-guided Neoadjuvant Therapy For Muscle-invasive Bladder Cancer' on July 01.

Brief Summary: This study evaluates Patient-derived Tumor-like Cell Clusters (PTC)-guided individualized neoadjuvant therapy in patients with muscle-invasive bladder cancer who are candidates for radical cystectomy.

Study Start Date: July, 2026

Study Type: INTERVENTIONAL

Condition: Bladder Cancer

Intervention: DRUG: PTC guided individualized neoadjuvant therapy

Fresh tumor tissue will be collected before neoadjuvant treatment to generate Patient-derived Tumor-like Cell Clusters (PTC) for ex vivo drug sensitivity testing. Based on the PTC results, ea...